تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
A multi-national, multi-centre, prospective, single-arm, observational, non-interventional post-authorisation safety study to investigate long-term safety of Sogroya®(somapacitan) in adults with growth hormone deficiency (AGHD) under routine clinical practice NovoNordisk Ongoing Sogroya® 4 NN8640-451 My Clinic (Jeddah)
A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study HemoShear Therapeutics, Terminated ST5040 (2,2-dimethylbutanoic acid) 4 HST20-CL01 King Faisal Specialist Hospital and Research Center (Riyadh)
Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients A Prospective, Multi-Centre, Double-Blind, Randomized, Controlled Trial. SPICE IV King Abdullah International Medical Research Center (KAIMRC) Ongoing DEXMEDETOMIDINE 4 SCT21R/006/04 King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers Qassim University Completed Vitamin C (ascorbic acid ) Cevital 3 20111803 Mental Health Hospital (Abha)
A phase II randomized study of the combination of Ribociclib plus goserelin acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptorpositive/HER2-negative inoperable locally advanced or metastatic breast cancer – RIGHT Choice Study. Novartis Terminated ribociclib 2 CLEE011A3201C King Faisal Specialist Hospital and Research Center (Riyadh)
A PHASE III, MULTICENTER, RANDOMISED, DOUBLEBLIND, PLACEBOCONTROLLED STUDY OF ATEZOLIZUMAB (ANTI−PDL1 ANTIBODY) IN COMBINATION WITH PACLITAXEL COMPARED WITH PLACEBO WITH PACLITAXEL FOR PATIENTS WITH PREVIOUSLY UNTREATED INOPERABLE LOCALLY ADVANCED OR METASTATIC TRIPLE NEGATIVE BREAST CANCER Roche Completed ATEZOLIZUMAB / PACLITAXEL 3 MO39196 IMC (Closed), KFSH (Closed), KFMC (Closed)
AN OPEN LABEL, SINGLE ARM, MULTICENTER,SAFETY STUDY OF ATEZOLIZUMAB IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL OR NON-UROTHELIAL CARCINOMA OF THE URINARY TRACT Roche Completed Atezolizumab (MPDL3280A; RO5541267) 3 MO29983 KFSH & RC-R
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia Ongoing WARFARIN SODIUM 3 2231351 King Faisal Specialist Hospital and Research Center (Riyadh)
A Randomized, Single Oral Dose, Open Label, Two Sequence, Two Treatment, Four Periods, Full Replicate Crossover Study to Determine the Bioequivalence of Azacitidine 300 mg Film Coated Tablets Versus Onureg® 300 mg Film Coated Tablets For Adult Patients with Acute Myeloid Leukaemia (AML) under Fasting Conditions Hikma Pharmaceuticals Ongoing Azacitidine 300 mg Film- Coated Tablets BE HIK-AZA-2023-01 King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh)
A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects with Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease Vertex Pharmaceuticals Ongoing Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) 3 VX21-CTX001-161 King Faisal Specialist Hospital and Research Center (Riyadh)
عرض 1 - 10 من 407